On August 30, 2021 Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, reported that the Aptose management team will participate at the upcoming conferences in September 2021 (Press release, Aptose Biosciences, AUG 30, 2021, View Source [SID1234586995]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

• H.C. Wainwright 23rd Annual Global Investment Conference

Date: Monday, September 13, 2021
Time: On demand starting 7:00 AM EDT
Format: Virtual
Webcast: Link

• Cantor Global Healthcare Conference

Date: Tuesday, September 28, 2021
Time: 11:20 AM EDT
Format: Virtual
Webcast: Link
The webcasts also can be accessed through the Aptose website at www.aptose.com and will be archived shortly after the live events.